Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)
- 1 January 1992
- journal article
- case report
- Published by Springer Nature in Drug Safety
- Vol. 7 (2) , 162-165
- https://doi.org/10.2165/00002018-199207020-00008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ETIDRONATE AND THE RISK OF FRACTURESThe Lancet, 1985
- Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).1983
- Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of boneMetabolic Bone Disease and Related Research, 1981
- CALCITONIN OR DIPHOSPHONATES FOR OSTEOLYTIC PAGET'S DISEASE?The Lancet, 1980
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977
- DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (E.H.D.P.) IN PAGET'S DISEASEThe Lancet, 1975
- Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.1974
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973
- Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.1973